---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-028201"
form_type: "8-K"
ticker: "BLFS"
cik: "0000834365"
company_name: "BIOLIFE SOLUTIONS INC"
filed_at: "2023-08-08T23:59:59+00:00"
generated_at: "2026-06-12T03:21:24.274698+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# BioLife Q2 revenue falls 3% to $39.5M; net loss $0.23/share; cuts FY guidance; plans freezer divest

## Summary
- Q2 2023 revenue $39.5M, down 3% YoY; cell processing up 22% but freezers down 26%.
- GAAP net loss $10.2M ($0.23 EPS); adjusted EBITDA -$1.2M vs +$1.2M a year ago.
- FY2023 revenue guidance lowered to $144M-$158M; previous cell processing guidance $89-93M now $65-74M.
- Committed to divest Stirling Ultracold and CBS freezer assets by end of 2023; focus on recurring higher-margin products.
- Pro forma H1 2023 revenue ex-freezers $51.5M; adj. gross margin 52%; adj. EBITDA margin 16-18%.

## SEC filing metadata
- accession: 0001628280-23-028201
- form_type: 8-K
- ticker: BLFS
- cik: 0000834365
- company_name: BIOLIFE SOLUTIONS INC
- filed_at: 2023-08-08T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/834365/000162828023028201/0001628280-23-028201-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/834365/000162828023028201/blfs-20230808.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-028201
- JSON: https://secwatch.observer/filing/0001628280-23-028201.json
- Plain text: https://secwatch.observer/filing/0001628280-23-028201.txt

## Key facts
- Earnings Releases
  BIOLIFE SOLUTIONS INC updated its second quarter ended June 30, 2023 guidance (reaffirmed).
  - Period: second quarter ended June 30, 2023
  - Guidance: reaffirmed
  - Result: reported results
  source text: On August 8, 2023, BioLife Solutions, Inc., a Delaware corporation, issued a press release announcing unaudited financial results and operational highlights for the second quarter ended June 30, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/834365/000162828023028201/0001628280-23-028201-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.